AFT-47-ARACOG
Phase II
OPEN TO ACCRUAL
A Randomized Phase II Study of Androgen Receptor Directed Therapy on COGnitive Function in Patients Treated with Darolutamide or Enzalutamide (ARACOG)
HCRN-GU19-385-PLANE-PC
Phase II
OPEN TO ACCRUAL
Phase II trial of Pembrolizumab and Lenvatinib in Advanced/Metastatic Neuroendocrine Prostate Cancer